Results revealed that in comparison with healthy controls, IGFBP2 presented up-regulation in glioma tissues, and had higher level in high-grade glioma tissues than that in low-grade glioma tissues (Fig. 4F and G). This evidence concerns the gene IGFBP2 and central nervous system cancer.